5-Aminolevulinic acid antiviral efficacy against SARS-CoV-2 omicron variant in vitro

Por Mya Myat Ngwe Tun, Takaya Sakura, Yasuteru Sakurai, Yohei Kurosaki, Daniel Ken Inaoka, Norifumi Shioda, Chris Smith, Jiro Yasuda, Kouichi Morita, Kiyoshi Kita
Publicado em 2022-04-01